TG Therapeutics: An Immunology Powerhouse | Latest News RSS feed

TG Therapeutics: An Immunology Powerhouse - Latest News

TG Therapeutics: An Immunology Powerhouse

Finances: Enough liquid assets to support the company until at least Q1 2019, with similar cash burns expected in the near future. Market potential by indication: $1.7 billion (relapsed/refractory CLL ... read more

Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies

Checkpoint and TG Therapeutics ... Checkpoint Therapeutics, Inc., to develop a portfolio of fully human immuno-oncology targeted antibodies generated in the laboratory of Dr. Wayne Marasco, MD, PhD, a ... read more

GSK Funds New Startup with Immunometabolic Focus

Backed by GlaxoSmithKline and Boston’s SV Health Investors, a new biopharmaceutical company known as Sitryx launched with $30 million in a Series A funding round to develop disease-modifying therapeut... read more

Looking for another news?

CDC researchers examine HIV-related stigma among US healthcare providers

About the Journal AIDS Patient Care and STDs is the leading peer-reviewed journal dedicated to diagnostics and therapeutics for providing ... LGBT Health, Transgender Health, Viral Immunology, and Jou... read more

Biotech firm raises $54M to hunt for cancer drugs

Gotham Therapeutics, a Manhattan-based biotech company ... well as prevention of disease in areas such as clinical chemistry and biology, toxicology and immunology, according to the hospital. The anat... read more

MichBio To Present Inaugural Michigan Bioscience Pantheon Award to Ten Inductees at Expo

During his tenure he transformed the organization into a medical technology powerhouse with unparalleled growth and ... He moved to Ann Arbor with Parke-Davis to head their allergy/immunology/pulmonar... read more

Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

Companies such as BioLineRx, Emergent BioSolutions, Infinity Pharmaceuticals, and TG Therapeutics are expected to enter ... and sells products across various therapy areas, including immunology, infec... read more

Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development

December 27, 2007 09:59 ET | Source: TG Therapeutics ... aesthetic and medical, dermatologic therapeutics. Prior to Revance, she was Senior Director, Medical Research, Immunology at Biogen Idec, Inc. ... read more

Flare-responsive hydrogel developed to treat arthritis

"Although new therapeutics have been developed ... The newly created flare-responsive hydrogel is made from triglycerol monostearate (TG-18), a compound from the Food and Drug Administration's list of ... read more

Asia Lung Cancer Summit in Hong Kong Targets Precision Medicine

And within this area, the Hong Kong-Shenzhen Innovation and Technology Park will be a powerhouse of research where great ... is investigating potential claims on behalf of investors of TG Therapeutics ... read more

Investors Should Exercise Caution With REVO Biologics IPO

Dr. Echelard currently serves as a director of TG Therapeutics (NASDAQ: TGTX) and as a director of GTC Biotherapeutics UK Limited. Dr. Echelard received a Ph.D. in microbiology and immunology from the ... read more

Spero Therapeutics to Participate in Anti-Infectives Panel Discussions at the 2017 Infectious Disease Summit

at 06:00 BioLineRx Increases Stake in BL-8040, its Lead Oncology Platform in Late Stage Development for Multiple Oncology Indications BioLineRx Ltd. , a clinical-stage biopharmaceutical company focuse... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us